Cargando…

The N6-methyladenosine reader protein YTHDC2 promotes gastric cancer progression via enhancing YAP mRNA translation

N6-methyladenosine (m(6)A) modification is the most prevalent internal modification in eukaryotic mRNA. YTH domain containing 2 (YTHDC2), a m(6)A binding protein, has recently been identified as a key player in human cancer. However, its contribution to gastric cancer (GC) remains unknown. Herein, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Wei, Chen, Shiqiang, Li, Bo, Han, Xiaoyu, Meng, Bo, Zou, Yongping, Chang, Shunwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8681016/ https://www.ncbi.nlm.nih.gov/pubmed/34911015 http://dx.doi.org/10.1016/j.tranon.2021.101308

Ejemplares similares

N(6)-methyladenosine reader protein YTHDC1 regulates influenza A virus NS segment splicing and replication
por: Zhu, Yinxing, et al.
Publicado: (2023)

The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection
por: Yin, Fanxing, et al.
Publicado: (2023)

RNA N(6)-methyladenosine reader YTHDC1 is essential for TGF-beta-mediated metastasis of triple negative breast cancer
por: Tan, Brandon, et al.
Publicado: (2022)

YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs
por: Roundtree, Ian A, et al.
Publicado: (2017)

Roles and mechanisms of the m(6)A reader YTHDC1 in biological processes and diseases
por: Yan, Huaqing, et al.
Publicado: (2022)

m(6)A reader YTHDC1 modulates autophagy by targeting SQSTM1 in diabetic skin
por: Liang, Diefei, et al.
Publicado: (2021)

Nuclear m6A reader YTHDC1 promotes muscle stem cell activation/proliferation by regulating mRNA splicing and nuclear export
por: Qiao, Yulong, et al.
Publicado: (2023)

Pathogenic variants in the human m(6)A reader YTHDC2 are associated with primary ovarian insufficiency
por: McGlacken-Byrne, Sinéad M., et al.
Publicado: (2022)

The m6A RNA Modification Quantity and the Prognostic Effect of Reader YTHDC2 in Colorectal Cancer
por: Liu, Tianyu, et al.
Publicado: (2022)

m(6)A in mRNA coding regions promotes translation via the RNA helicase-containing YTHDC2
por: Mao, Yuanhui, et al.
Publicado: (2019)

A potassium-chloride co-transporter promotes tumor progression and castration resistance of prostate cancer through m(6)A reader YTHDC1
por: Yuan, Shuai, et al.
Publicado: (2023)

The m6A reader YTHDC1-mediated lncRNA CTBP1-AS2 m6A modification accelerates cholangiocarcinoma progression
por: Jin, Zhe, et al.
Publicado: (2023)

The m(6)A reader YTHDC2 is essential for escape from KSHV SOX-induced RNA decay
por: Macveigh-Fierro, Daniel, et al.
Publicado: (2022)

Depletion of m(6)A reader protein YTHDC1 induces dilated cardiomyopathy by abnormal splicing of Titin
por: Gao, Siyun, et al.
Publicado: (2021)

Downregulation of m(6)A reader YTHDC2 promotes tumor progression and predicts poor prognosis in non‐small cell lung cancer
por: Sun, Shulei, et al.
Publicado: (2020)

Nuclear m(6)A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development
por: Kasowitz, Seth D., et al.
Publicado: (2018)

YTHDC2-Mediated circYTHDC2 N6-Methyladenosine Modification Promotes Vascular Smooth Muscle Cells Dysfunction Through Inhibiting Ten-Eleven Translocation 2
por: Yuan, Jun, et al.
Publicado: (2021)

m(6)A Reader: Epitranscriptome Target Prediction and Functional Characterization of N(6)-Methyladenosine (m(6)A) Readers
por: Zhen, Di, et al.
Publicado: (2020)

N6-methyladenosine (m6A) reader Pho92 is recruited co-transcriptionally and couples translation to mRNA decay to promote meiotic fitness in yeast
por: Varier, Radhika A, et al.
Publicado: (2022)

The m(6)A reader protein YTHDC2 interacts with the small ribosomal subunit and the 5′–3′ exoribonuclease XRN1
por: Kretschmer, Jens, et al.
Publicado: (2018)

Multiple Phosphorylations of SR Protein SRSF3 and Its Binding to m(6)A Reader YTHDC1 in Human Cells
por: Tatsuno, Takanori, et al.
Publicado: (2022)

The m(6)A reader YTHDC1 and the RNA helicase DDX5 control the production of rhabdomyosarcoma-enriched circRNAs
por: Dattilo, Dario, et al.
Publicado: (2023)

Nuclear m(6)A reader YTHDC1 regulates the scaffold function of LINE1 RNA in mouse ESCs and early embryos
por: Chen, Chuan, et al.
Publicado: (2021)

Low expression of m6A reader YTHDC1 promotes progression of ovarian cancer via PIK3R1/STAT3/GANAB axis
por: Wang, Xiaogang, et al.
Publicado: (2023)

Nuclear Aurora kinase A switches m(6)A reader YTHDC1 to enhance an oncogenic RNA splicing of tumor suppressor RBM4
por: Li, SiSi, et al.
Publicado: (2022)

RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA
por: Fan, Jin, et al.
Publicado: (2023)

The m6A reader YTHDC1 regulates muscle stem cell proliferation via PI4K–Akt–mTOR signalling
por: Liu, Jin, et al.
Publicado: (2023)

H19 recruited N(6)-methyladenosine (m(6)A) reader YTHDF1 to promote SCARB1 translation and facilitate angiogenesis in gastric cancer
por: Bai, Rumeng, et al.
Publicado: (2023)

The m(6)A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function
por: Ma, Lifang, et al.
Publicado: (2020)

The m6A reader protein YTHDC2 is a potential biomarker and associated with immune infiltration in head and neck squamous cell carcinoma
por: Li, Yang, et al.
Publicado: (2020)

Correction to: Nuclear m6A reader YTHDC1 regulates the scaffold function of LINE1 RNA in mouse ESCs and early embryos
por: Chen, Chuan, et al.
Publicado: (2021)

YTHDC1 mitigates ischemic stroke by promoting Akt phosphorylation through destabilizing PTEN mRNA
por: Zhang, Zhaolong, et al.
Publicado: (2020)

N(6)-methyladenosine (m(6)A) reader IGF2BP2 promotes gastric cancer progression via targeting SIRT1
por: Zhang, Zili, et al.
Publicado: (2022)

Downregulation of m(6)A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-κB Pathway
por: Wang, Jin, et al.
Publicado: (2021)

Ythdf is a N6‐methyladenosine reader that modulates Fmr1 target mRNA selection and restricts axonal growth in Drosophila
por: Worpenberg, Lina, et al.
Publicado: (2021)

YTH Domain: A Family of N(6)-methyladenosine (m(6)A) Readers
por: Liao, Shanhui, et al.
Publicado: (2018)

YTHDC2 inhibits rat bone mesenchymal stem cells osteogenic differentiation by accelerating RUNX2 mRNA degradation via m6A methylation
por: Ma, Bo, et al.
Publicado: (2023)

N(6)-methyladenosine in mRNA disrupts tRNA selection and translation elongation dynamics
por: Choi, Junhong, et al.
Publicado: (2016)

m(6)A Reader YTHDC2 Promotes Radiotherapy Resistance of Nasopharyngeal Carcinoma via Activating IGF1R/AKT/S6 Signaling Axis
por: He, Jun-Ju, et al.
Publicado: (2020)

Overexpression of m6A-factors METTL3, ALKBH5, and YTHDC1 alters HPV16 mRNA splicing
por: Cui, Xiaoxu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_btvn78makrf2epngj8vvd7v30f